Pioglitazone Tablet
Product Images NDC 0904-7096

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 0904-7096). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6845f5ef 5196 47ba B4ba Ad39ef9cc2d2 00

6845f5ef 5196 47ba B4ba Ad39ef9cc2d2 00
This is a description for a medication called Pioglitazone. The medication comes in tablet form and is packaged in a unit dose with 100 tablets. Each tablet contains Pioglitazone hydrochloride, which is an SP equivalent to Plogitazone 30. The dosage varies based on the prescription and should be taken in accordance with instructions from a pharmacist or healthcare provider. The medication guide should be reviewed before taking this medication. The remaining text contains unclear characters and cannot be translated.*
FDA Label Image

6845f5ef 5196 47ba B4ba Ad39ef9cc2d2 01

6845f5ef 5196 47ba B4ba Ad39ef9cc2d2 01
PIOGLITAZONE is a prescription drug, also known as tablets, USP that are available as a unit dose of 100 tablets with NDC 0904-7080-61 and only can be obtained with a medical prescription. Unfortunately, the text also contains some unreadable characters and numbers that do not make sense, probably due to .*
FDA Label Image

Figure 1. Mean Change From Baseline For Hba1c In A 26-week Placebo-controlled Dose-ranging Study (observed Values) (Pioglitazone Fig1)

Figure 1. Mean Change From Baseline For Hba1c In A 26-week Placebo-controlled Dose-ranging Study (observed Values) (Pioglitazone Fig1)
The figure shows the mean change from the baseline for HbAlc in a 26-week placebo-controlled dose-ranging study. The values displayed are observed, and the x-axis represents the number of weeks, while the y-axis represents the mean change. The study tested three doses of an unnamed drug, indicated by the key at the bottom of the figure as 15mg, 30mg, and 45mg. There is no specific information available about the drug being tested or the reason for the study.*
FDA Label Image

Chemical Structure (Pioglitazone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.